EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases

Ismail Ogulur, Yagiz Pat, Duygu Yazici, Sena Ardicli, Ozge Ardicli, Yasutaka Mitamura, Mübeccel Akdis, Cezmi A Akdis

Current Opinion in Immunology · 2024-12 · 91 · 102493

DOI: 10.1016/j.coi.2024.102493 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Immunology, 2024-12. Verfasst von Ismail Ogulur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Hauptthemen laut MEDLINE: Inflammation. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 150 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, humans have been increasingly exposed to substances toxic for epithelial cells, including air pollutants, laundry and dishwashers, household chemicals, toothpaste, food additives, microplastics, and nanoparticles, introduced into our daily lives as part of industrialization, urbanization, and modernization. These substances disrupt the epithelial barriers and lead to microbial dysbiosis and cause immune response to allergens, opportunistic pathogens, bacterial toxins, and autoantigens followed by chronic inflammation due to epigenetic mechanisms. Recent evidence from studies on the mechanisms of epithelial barrier damage has demonstrated that even trace amounts of toxic substances can damage epithelial barriers and induce tissue inflammation. Further research in this field is essential for our understanding of the causal substances and molecular mechanisms involved in the initiation of leaky epithelial barriers that cascade into chronic inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationAnimalsHumansChronic DiseaseEpithelial Cells

Autor:innen und Institutionen

  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Electronic address: akdisac@siaf.uzh.ch.

Zitieren

APA

Ogulur, I., Pat, Y., Yazici, D., Ardicli, S., Ardicli, O., Mitamura, Y., Akdis, M., & Akdis, C. A. (2024). Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases. Current Opinion in Immunology, 91, 102493. https://doi.org/10.1016/j.coi.2024.102493

Vancouver

Ogulur I, Pat Y, Yazici D, Ardicli S, Ardicli O, Mitamura Y, et al. Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases. Current Opinion in Immunology. 2024;91:102493. doi:10.1016/j.coi.2024.102493

BibTeX
@article{Ogulur2024,
  author = {Ogulur, Ismail and Pat, Yagiz and Yazici, Duygu and Ardicli, Sena and Ardicli, Ozge and Mitamura, Yasutaka and Akdis, Mübeccel and Akdis, Cezmi A},
  title = {Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases},
  journal = {Current Opinion in Immunology},
  year = {2024},
  volume = {91},
  pages = {102493},
  doi = {10.1016/j.coi.2024.102493}
}
Kostenlos starten →